Impact of elexacaftor-tezacaftor-ivacaftor in lung transplantation for cystic fibrosis in the United States

Impact of elexacaftor-tezacaftor-ivacaftor in lung transplantation for cystic fibrosis in the United States

Background: Cystic fibrosis (CF) is an autosomal recessive condition leading to progressive lung disease and often necessitating lung transplantation. Historically, CF has been one of the leading indications for lung transplants in the United States. The advent of CF transmembrane conductance regula...

Full description

Saved in:
Bibliographic Details
Main Authors: Tahuanty A. Pena, MD, MS, Brittany Wright, PharmD, Kalpaj R. Parekh, MBBS, Julia Kleney-Tait, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:JHLT Open
Subjects:
elexacaftor
tezacaftor
ivacaftor
cystic fibrosis
lung transplant
Online Access:http://www.sciencedirect.com/science/article/pii/S2950133424001204
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items